Pharmafile Logo
Pharmafocus logo
Advanced Search
Blog footer

Digital Pharma: Bayer reprimanded over social media use

August 17, 2011
Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA

Bayer will be named in the medical press after being found guilty of the first social media breach of the …

News

NICE to review Lucentis decision

August 17, 2011
Sales and Marketing Lucentis, NICE, diabetic macular edema

NICE will allow an appeal against its decision not to recommend Novartis’s Lucentis for diabetic macular oedema. The appeal came …

News

Sanofi Pasteur MSD appoints new UK medical director

August 17, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Sanofi Pasteur MSD has appointed Dr Aidrian Kilcoyne as medical director in the UK. He joins the company from Roche …

Appointment

NICE wants more information on Pradaxa

August 17, 2011
Sales and Marketing NICE, Pradaxa

NICE has asked for more information on Pradaxa, after deciding in preliminary guidance that the drug is not cost-effective in …

News

Pfizer triumphs in US Viagra patent trial

August 17, 2011
Sales and Marketing Pfizer, generics, viagra

Pfizer has won a US patent infringement case against generics giant Teva, stopping the company from making its own version …

News

Contract research news in brief

August 17, 2011
Research and Development research and development news

Our round-up of news from the contract research sector includes the rejection of a cancer drug by the FDA because …

News

How the best labs manage talent

August 16, 2011
Business Services, Manufacturing and Production, Research and Development careers, recruitment, talent retention

Of the $1.2 trillion spent globally each year on R&D across corporations and academia, 40 per cent – much the …

Feature

Onyx Scientific bought by India’s Ipca Labs

August 16, 2011
Manufacturing and Production, Research and Development Ipca, Onyx, contract research news, pharma manufacturing news, research and development news

India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …

News

Contract manufacturing market set for return to growth

August 16, 2011
Manufacturing and Production contract manufacturing, pharma manufacturing news

The pharmaceutical contract manufacturing sector looks set for a return to historical growth over the next five years, after a …

News

New head of oncology for Astellas Pharma Europe

August 16, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Astellas Pharma has appointed Dr Christopher Thomson as executive director of its new European Oncology Unit.   Dr Thomson will …

Appointment

Pharma manufacturing news in brief

August 16, 2011
Manufacturing and Production pharma manufacturing news

Jubilant announces an $80 million agreement to supply an unnamed product over the next three years, plus there are facility …

News
GlaxoSmithKline

GSK Parkinson’s drug shows motor skills benefits

August 16, 2011
Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

News

Digital Pharma: Pharma adapts to new era on Facebook

August 15, 2011
Medical Communications Digital Pharma blog, Facebook

Pharma companies must adapt to a new level of engagement on Facebook after new rules from the social network forcing …

News

Afrezza could breathe new life into inhaled insulin market

August 15, 2011
Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news

New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …

News

Study shows new genetic risk factors for MS

August 15, 2011
Research and Development genes, multiple sclerosis, research and development news

New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …

News

Ranbaxy closes down troubled liquid formulations plant

August 12, 2011
Manufacturing and Production FDA, Ranbaxy, pharma manufacturing news, quality control

Indian drugmaker Ranbaxy Laboratories has decided to close down a manufacturing facility in the USA which has been under scrutiny …

News

GSK moves into diagnostics with Enigma

August 12, 2011
Sales and Marketing Diagnostics, GSK, infectious diseases

GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …

News

Online learning for non-medical prescribers launched

August 12, 2011
Medical Communications Pfizer, Prescriber, medical education, non medical prescribing

Therapeutics PLUS, a free online medical education offering to healthcare professionals has been re-launched. The online resource has been created …

News
Kano, Nigeria, drug trial

Pfizer pays compensation to Nigerian trial victims

August 12, 2011
Kano, Pfizer, Trovan, misconduct, out of court

Pfizer has paid out the first compensation to families of children who died during a meningitis drug trial in Nigeria. …

News

Triple regimen HIV pill gains approval

August 11, 2011
Gilead, HIV, J&J, JJ, Truvada

A new three-in-one pill Complera has been approved in the US as a first line treatment for HIV. Complera combines …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026